EGF and lipoprotein glomerulopathy: Already in an early phase, tubulo-interstitial changes induced by glomerulopathies lead to diminished production and urinary excretion of epidermal growth factor (EGF), making urinary EGF a sensitive and ‘early stage’ biomarker for the deterioration of kidney function [12].